Skip to main content
Clinical Trials/NCT00987883
NCT00987883
Unknown
Not Applicable

Malnutrition and Its Impact on the Perioperational Hospitalization Cost: A Prospective, Cohort Study on Gastroenterological Cancer Patients

Peking Union Medical College Hospital1 site in 1 country200 target enrollmentApril 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malnutrition
Sponsor
Peking Union Medical College Hospital
Enrollment
200
Locations
1
Primary Endpoint
Cost
Last Updated
16 years ago

Overview

Brief Summary

Undernutrition is a state marked by energy and/or protein intake deficiency or mal-absorption, and is often described as protein energy malnutrition (PEM). Malnutrition is common in hospitalized patients worldwide. The prevalence of malnutrition in hospitalized patients range from 20% - 50%, depends on the varieties of diseases, health system, population and assessment tools. It is well documented in Western countries that malnutrition affects clinical outcomes negatively. Compared with well-nourished patients, patients with malnutrition stay longer in hospitals and related cost is significantly higher.

There is increasing evidence which indicates that appropriate nutrition support (e.g., standardized nutrition screening procedures, delivering nutrients with appropriate path, etc) may improve clinical outcome on malnutrition, along with cost saving.

To date, there is no study to document specifically the impact of malnutrition and related nutrition support on the health economics in China. Considering China now is on its way to establish public health security system and a diagnosis-related grouping system, the understanding of the cost effectiveness of nutrition support under the current clinical conditions is crucial.

This study aims to investigate the prevalence of perioperational malnutrition in gastroenterological cancer patient, the nutrition support status and related health economic effects.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
December 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • With gastroenterological cancer
  • Will receive resectional operation
  • Consent informed

Exclusion Criteria

  • With severly cardiac, pulmonary, liver or renal disease
  • With endocrine or metabolic disease
  • With dyslipidemia
  • Without consent

Outcomes

Primary Outcomes

Cost

Time Frame: 30 days after operation

Secondary Outcomes

  • Length of hospitalization(30 days after operation)
  • Mortality(30 days after operation)
  • Infectious morbidity(30 days after operation)

Study Sites (1)

Loading locations...

Similar Trials